In the wake of President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to oversee the Department of Health and Human Services, healthcare stocks experienced a significant downturn. Notably, vaccine manufacturers such as Moderna saw stocks plummet by over 5%, while major players like Pfizer experienced a 2% drop. Analysts on Wall Street suggested that...
Premium Membership Required
You must be a Premium member to access this content.
Already a member? Log in here